NCT03604003 is a NA clinical trial of potassium losartan in Chronic Kidney Disease, sponsored by Fifth Affiliated Hospital, Sun Yat-Sen University.

Who is sponsoring NCT03604003?

NCT03604003 is sponsored by Fifth Affiliated Hospital, Sun Yat-Sen University.

What drugs are being tested in NCT03604003?

Interventions in NCT03604003: potassium losartan.

What condition does NCT03604003 study?

NCT03604003 studies Chronic Kidney Disease.

Is NCT03604003 still recruiting?

NCT03604003 is currently status unknown. Last updated 27 July 2018.

Last reviewed 2018-07-27 · How we verify

NCT03604003

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Role of Isolated Nocturnal Hypertension Pattern in Nondialysis CKD

Status unknown NA Last updated 27 July 2018

What this trial tests

NA trial testing potassium losartan in Chronic Kidney Disease in 252 participants. Status unknown.

Timeline

30 November 2018

Primary endpoint
30 June 2021

30 December 2023

Quick facts

Lead sponsor	Fifth Affiliated Hospital, Sun Yat-Sen University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	252
Start date	30 November 2018
Primary completion	30 June 2021
Estimated completion	30 December 2023

Drugs / interventions tested

potassium losartan — full drug profile →

Conditions studied

Chronic Kidney Disease — all drugs for Chronic Kidney Disease →

Sponsor

Fifth Affiliated Hospital, Sun Yat-Sen University

Who can join

Adults 14 to 75, any sex, with Chronic Kidney Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Isolated nocturnal hypertension (INH) has been studied among the general population and hypertensive patients. However, little insight is available on the prognostic effect of INH in patients with chronic kidney disease (CKD). This study investigated the prognostic effect of INH in a cohort of Chinese patients with nondialysis CKD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of potassium losartan

Trials testing the same drug.

NCT03603938 — Bedtime Potassium Losartan on CKD With Nocturnal Hypertension Patients With Nondipping Blood Pressure Pattern · NA · unknown

Other recruiting trials for Chronic Kidney Disease

Currently open trials in the same condition.

NCT07469540 — Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid Arth · NA · recruiting
NCT07169422 — Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care · NA · recruiting
NCT07481526 — A Prospecitve Multicenter, Observational Registry Study · recruiting
NCT07450820 — OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD · recruiting
NCT07107945 — A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease · Phase 3 · recruiting

Other Fifth Affiliated Hospital, Sun Yat-Sen University trials

Trials by the same sponsor.

NCT06079931 — The Efficacy of Babaodan Capsules in Preventing Radiation Pneumonia · Phase 2 · unknown
NCT06525025 — Building a Traditional Chinese Medicine Clinical Diagnosis and Treatment Database · not yet recruiting
NCT06060782 — Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine · Phase 1 · recruiting
NCT06220552 — The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma · Phase 2 · recruiting
NCT06147947 — Liver and Spleen Stiffness Measured by TE and 2D-SWE for Diagnosis of CSPH in Patients With cACLD · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03604003 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fifth Affiliated Hospital, Sun Yat-Sen University
Last refreshed: 27 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03604003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing